The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 ...

But they've also been the source of persistent safety problems. In the past five years, the FDA has received more than 56,000 reports of adverse events associated with the use of infusion pumps. Those ...

Despite increasing chemoradiotherapy treatment, there is a paucity of information regarding the effects of radiation exposure on ambulatory infusion pumps used to deliver chemotherapy or other ...

On April 30, FDA sent a letter to Baxter Healthcare Corp. ordering the company to recall and destroy all of its Colleague Volumetric infusion pumps currently in use in the United States. This action, ...

The rapid development of pharmaceuticals and prescribed combinations has made administering intravenous drug therapy more involved than ever before, leading to a new generation of “smart pumps” ...

Elastomeric infusion pumps are advanced, non-electronic medical devices that enable controlled, continuous drug delivery in home care, hospice, and ambulatory settings. These devices are commonly used ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced a new initiative to address safety problems associated with external infusion pumps and is ...

February 24, 2011 — The US Food and Drug Administration (FDA) has issued a Class I recall for certain lots of implantable infusion pumps manufactured by Medtronic, which are used in patients ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Food ad Drug Administration has issued a class 1 recall notice for model 35700 SIGMA Spectrum Infusion ...

A new collaboration announced between Cerner and Hospira will integrate Hospira’s infusion pump data into Cerner’s EMR. Hospira will use Cerner’s CareAware program, an interoperable communication ...